Difference between Pancreatic Neuroendocrine tumor and Pancreatic Cancer | #cancer #treatment

A pancreatic neuroendocrine tumor (NET) is a type of disease that forms tumors in the pancreas.

Pancreatic adenocarcinoma(cancer) occurs when exocrine cells (cells that produce digestive enzymes) grow out of control.

However, Pancreatic neuroendocrine tumors occur when endocrine cells (cells that make blood sugar-stabilizing hormones like insulin) grow out of control.

Pancreatic neuroendocrine tumors may be benign (not cancer) or malignant (cancer). When pancreatic NETs are malignant, they are called pancreatic endocrine cancer.

Watch The Video to Know More.

Dr. Vinay Samuel Gaikwad (Director -Surgical Oncology @ CK Birla Hospital) is a profound doctor with vast experience of more than 14 years in the field of Surgical Oncology and has been trained from Tata Memorial Hospital, Mumbai & MSKCC, New York, currently associated with Paras Cancer Centre-Paras Hospital - Gurgaon, India. He has an expertise in highly specialized Minimally Invasive Cancer Surgeries such as surgeries of the Colon, Rectum, Stomach, Esophagus, Pancreas, Liver & Gall Bladder. He also performs most advanced cancer surgeries like #HIPEC & #PIPAC procedures and has operated more than 50 such cases till now. Dr. Gaikwad continually strives to deliver superior outcomes while remaining patient-centered.

Contact/Appointment @ +91 99109 76320 / +91 95996 45743
or write to "vinay@drvinayonco.com" or "vinaysgaikwad@gmail.com"

For more info kindly visit @ www.drvinayonco.com
Followus @ FB.com/DrVinayOnco & Twitter.com/DrVinayOnco

#colorectalcancer #bladdercancer #cancertreatment #cancersurgery #surgery #urologytreatment #colontreatment #coloncancer #gurgaon #treatment #pancreas #pancreaticcancer

Pancreatic Neuroendocrine tumor
Pancreatic Cancer
Cancer Surgery
Oncologist

Dr. Anand Sahai MD, MSc (Epid), FRCPC, Associate Professor of Medicine, Chief, Division of Gastroenteology at Centre Hospitalier de l'Universite de Montreal in Montreal Quebec, demonstrates the EchoTip® Ultra® HD Endoscopic Ultrasound Needle.

EchoTip® Ultra® HD Endoscopic Ultrasound Needle .

INSTRUCTIONS FOR USE (IFU):
https://www.cookmedical.com/da....ta/IFU_PDF/IFU0101-2
MORE INFO:
https://www.cookmedical.com/pr....oduct/-/catalog/disp

INTENDED USE: This device is used to sample targeted submucosal gastrointestinal lesions through the accessory channel of an ultrasound endoscope.

NOTES: This device is designed for single use only. Attempts to reprocess, resterilize, and/or reuse may lead to device failure and/or transmission of disease.
Do not use this device for any purpose other than stated intended use.
If package is opened or damaged when received, do not use. Visually inspect with particular attention to kinks, bends and breaks. If an abnormality is detected that would prohibit proper working condition, do not use. Please notify Cook for return authorization.
Store in a dry location, away from temperature extremes.
Use of this device restricted to a trained healthcare professional.

CONTRAINDICATIONS: Those specific to primary endoscopic procedure to be performed in gaining access to desired site.
Coagulopathy.

POTENTIAL COMPLICATIONS: Those associated with gastrointestinal endoscopy include, but are not limited to: perforation, hemorrhage, aspiration, fever, infection, allergic reaction to medication, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest.

PRECAUTIONS: Refer to package label for minimum channel size required for this device.
Needle must be retracted into sheath and thumbscrew on safety ring must be locked to hold needle in place prior to introduction, advancement or withdrawal of device. Failure to retract needle may result in damage to endoscope.

Rodney F. Pommier, MD, discusses surgical debulking and embolization for the treatment of hepatic metastases in patients with pancreatic neuroendocrine tumors.

To view more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

Neuroendocrine tumours (NETs) are a rare type of tumour that can form in the neuroendocrine system. These may be in the gut, the lungs or the pancreas. Symptoms differ depending on where the tumours form. Dr Christos Toumpankis, a leading gastroenterologist, explains what NETs are, the symptoms, how they are diagnosed and how they can be treated.

Book now with Dr Toumpanakis: https://www.topdoctors.co.uk/d....octor/christos-toump

Panelists discuss two clinical trials demonstrating that somatostatin analogs have an antiproliferative effect in patients with neuroendocrine tumors.

To view more from this conversation, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

Panelists discuss the effectiveness of alkylating agents, specifically temozolomide, in the treatment of patients with pancreatic neuroendocrine tumors.

To view more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

For more, visit our website at https://www.CTisus.com

Check out the apple app store for CTisus apps https://tinyurl.com/y2pyjzhv

Keep in Touch at:
Facebook: http://facebook.com/CTisus
Twitter: http://twitter.com/CTisus
Instagram: http://instagram.com/CTisus_radiology
Pinterest: http://pinterest.com/CTisus_radiology
LinkedIn: http://linkedin.com/company/CTisus

Rodney F. Pommier, MD, Jonathan R. Strosberg, MD, and Diane Reidy-Lagunes, MD, MS, discuss several hypothetical scenarios in patients with pancreatic neuroendocrine tumors.

For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne